NILIF yields 477.51% · JNJ yields 2.13%● Live data
📍 NILIF pulled ahead of the other in Year 1
Combined, NILIF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NILIF + JNJ for your $10,000?
Surge Battery Metals Inc., an exploration stage company, engages in the acquisition, exploration, and development of mineral properties in North America. It focuses on gold, copper, lead, zinc, silver, cobalt, nickel, and precious metals. The company has an option to acquire 60% interests in two principal cobalt properties, including the Teledyne Cobalt property and the Glencore Bucke Cobalt property located in Ontario, Canada; and holds interest in the Nevada North lithium project that comprises of 154 mineral claims covering an area of approximately 794 hectares. It also has an option to acquire a 100% interest in the Quatse Lake property comprising four mineral claims covering an area of 1,786 hectares located in British Columbia; a 80% interest in the San Emidio Desert Lithium project comprising 35 mineral claims that covers an area of 2800 acres located to the North East of Reno, Nevada; and a 80% interest in the Nickel project located in British Columbia. The company was formerly known as Copper Creek Gold Corp. and changed its name to Surge Exploration Inc. in April 2018. Surge Battery Metals Inc. was incorporated in 1987 and is headquartered in Vancouver, Canada.
Full NILIF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.